. .. Introduction,

. Materials and . .. Methods,

. .. Results,

. .. Discussion,

. .. Discussion,

R. .. Complementaires,

. .. Effets-de-la-prémédication-par-carbidopa,

.. .. Effets-selon-le-statut-tabagique,

C. .. ,

B. .. ,

V. De and L. R. ,

. .. Permis-d'imprimer,

R. Bauer, E. Toepper, M. Gebhardt, H. Gallhofer, B. Sammer et al., The significance of caudate volume for age-related associative memory decline, Brain Res, vol.1622, pp.137-148, 2015.

I. Chang, K. Lue, H. Hsieh, S. Liu, and C. K. Kao, Automated striatal uptake analysis of 18 F-FDOPA PET images applied to Parkinson's disease patients, 2011.

, Ann. Nucl. Med, vol.25, pp.796-803

M. Cordes, B. J. Snow, S. Cooper, M. Schulzer, B. D. Pate et al., Age-dependent decline of nigrostriatal dopaminergic function: a positron emission tomographic study of grandparents and their grandchildren, Ann. Neurol, vol.36, pp.667-670, 1994.

J. Darcourt, A. Schiazza, N. Sapin, M. Dufour, M. J. Ouvrier et al., 18F-FDOPA PET for the diagnosis of parkinsonian syndromes, Q. J. Nucl. Med. Mol. Imaging Off. Publ. Ital. Assoc. Nucl. Med. AIMN Int. Assoc. Radiopharmacol. IAR Sect. Soc. Of, vol.58, pp.355-365, 2014.

I. Driscoll, C. Davatzikos, Y. An, X. Wu, D. Shen et al., Longitudinal pattern of regional brain volume change differentiates normal aging from MCI, Neurology, vol.72, pp.1906-1913, 2009.

D. Eidelberg, S. Takikawa, V. Dhawan, T. Chaly, W. Robeson et al., Striatal 18F-dopa uptake: absence of an aging effect, J. Cereb. Blood Flow Metab. Off. J. Int. Soc. Cereb. Blood Flow Metab, vol.13, pp.881-888, 1993.

A. Eusebio, J. Azulay, M. Ceccaldi, N. Girard, O. Mundler et al., Voxelbased analysis of whole-brain effects of age and gender on dopamine transporter SPECT imaging in healthy subjects, Eur. J. Nucl. Med. Mol. Imaging, vol.39, pp.1778-1783, 2012.

A. M. Fjell, L. T. Westlye, I. Amlien, T. Espeseth, I. Reinvang et al., High consistency of regional cortical thinning in aging across multiple samples, Cereb. Cortex N. Y. N, 2001.

C. L. Gallagher, B. Bell, M. Palotti, J. Oh, B. T. Christian et al., Anterior cingulate dopamine turnover and behavior change in Parkinson's disease, Brain Imaging Behav, vol.9, pp.821-827, 2015.

C. L. Gallagher, T. R. Oakes, S. C. Johnson, M. K. Chung, J. E. Holden et al., Rate of 6-[18F]fluoro-L-dopa uptake decline in striatal subregions in Parkinson's disease, Mov. Disord. Off. J. Mov. Disord. Soc, vol.26, pp.614-620, 2011.

F. J. García-gómez, D. García-solís, F. J. Luis-simón, V. A. Marín-oyaga, F. Carrillo et al., , 2013.

, Rev. Espanola Med. Nucl. E Imagen Mol, vol.32, pp.350-356

P. Giompres and F. Delis, Dopamine transporters in the cerebellum of mutant mice, Cerebellum Lond. Engl, vol.4, pp.105-111, 2005.

J. D. Gispert, J. Pascau, S. Reig, R. Martínez-lázaro, V. Molina et al., Influence of the normalization template on the outcome of statistical parametric mapping of PET scans, NeuroImage, vol.19, pp.601-612, 2003.

S. M. Grieve, C. R. Clark, L. M. Williams, A. J. Peduto, and E. Gordon, Preservation of limbic and paralimbic structures in aging, Hum. Brain Mapp, vol.25, pp.391-401, 2005.

J. M. Hoffman, W. P. Melega, T. C. Hawk, S. C. Grafton, A. Luxen et al., The Effects of Carbidopa Administration on 6-[18F]Fluoro-L-DOPA Kinetics in Positron Emission Tomography, J. Nucl. Med, vol.33, pp.1472-1477, 1992.

J. A. Hosp and A. R. Luft, Dopaminergic meso-cortical projections to m1: role in motor learning and motor cortex plasticity. Front. Neurol. 4, p.145, 2013.

J. C. Houk and S. P. Wise, Distributed modular architectures linking basal ganglia, cerebellum, and cerebral cortex: their role in planning and controlling action, Cereb. Cortex N. Y. N, vol.5, pp.95-110, 1991.

S. Ikemoto, Brain reward circuitry beyond the mesolimbic dopamine system: A neurobiological theory, Neurosci. Biobehav. Rev, vol.35, pp.129-150, 2010.

A. Jaimini, M. Tripathi, M. M. Souza, P. Panwar, R. Sharma et al., Utility of intrastriatal ratios of FDOPA to differentiate idiopathic Parkinson's disease from atypical parkinsonian disorders, Nucl. Med. Commun, vol.34, pp.426-431, 2013.

P. Jokinen, H. Helenius, E. Rauhala, A. Brück, O. Eskola et al., Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls, J. Nucl. Med. Off. Publ. Soc. Nucl. Med, vol.50, pp.893-899, 2009.

P. Jokinen, M. Karrasch, A. Brück, J. Johansson, J. Bergman et al., Cognitive slowing in Parkinson's disease is related to frontostriatal dopaminergic dysfunction, J. Neurol. Sci, vol.329, pp.23-28, 2013.

J. H. Kordower, C. W. Olanow, H. B. Dodiya, Y. Chu, T. G. Beach et al., Disease duration and the integrity of the nigrostriatal system in Parkinson's disease, Brain J. Neurol, vol.136, pp.2419-2431, 2013.

A. Laakso, H. Vilkman, J. Bergman, M. Haaparanta, O. Solin et al., Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects, Biol. Psychiatry, vol.52, pp.759-763, 2002.

C. T. Li, M. Palotti, J. E. Holden, J. Oh, O. Okonkwo et al., A dual-tracer study of extrastriatal 6-[18F]fluoro-m-tyrosine and 6-[18F]fluoro-L-dopa uptake in Parkinson's disease, vol.68, pp.325-331, 2014.

X. Long, W. Liao, C. Jiang, D. Liang, B. Qiu et al., Healthy aging: an automatic analysis of global and regional morphological alterations of human brain, Acad. Radiol, vol.19, pp.785-793, 2012.

S. K. Madsen, A. J. Ho, X. Hua, P. S. Saharan, A. W. Toga et al., Alzheimer's Disease Neuroimaging Initiative, 2010. 3D maps localize caudate nucleus atrophy in 400 Alzheimer's disease, mild cognitive impairment, and healthy elderly subjects, Neurobiol. Aging, vol.31, pp.1312-1325

W. R. Martin, M. R. Palmer, C. S. Patlak, and D. B. Calne, Nigrostriatal function in humans studied with positron emission tomography, Ann. Neurol, vol.26, pp.535-542, 1989.

E. Niven, M. Thompson, and C. Nahmias, Absorbed dose to the adult male and female brain from 18F-fluorodeoxyglucose, Health Phys, vol.80, pp.62-66, 2001.

J. D. Ragland, A. R. Coleman, R. C. Gur, D. C. Glahn, and R. E. Gur, Sex differences in brain-behavior relationships between verbal episodic memory and resting regional cerebral blood flow, Neuropsychologia, vol.38, pp.451-461, 2000.

G. V. Sawle, J. G. Colebatch, A. Shah, D. J. Brooks, C. D. Marsden et al., Striatal function in normal aging: implications for Parkinson's disease, Ann. Neurol, vol.28, pp.799-804, 1990.

M. Soret, S. L. Bacharach, and I. Buvat, Partial-volume effect in PET tumor imaging, J. Nucl. Med. Off. Publ. Soc. Nucl. Med, vol.48, pp.932-945, 2007.

E. R. Sowell, B. S. Peterson, P. M. Thompson, S. E. Welcome, A. L. Henkenius et al., Mapping cortical change across the human life span, Nat. Neurosci, vol.6, pp.309-315, 2003.

A. F. Struck, L. T. Hall, J. E. Kusmirek, C. L. Gallagher, J. M. Floberg et al., (18)F-DOPA PET with and without MRI fusion, a receiver operator characteristics comparison, Am. J. Nucl. Med. Mol. Imaging, vol.2, pp.475-482, 2012.

Y. Taki, B. Thyreau, S. Kinomura, K. Sato, R. Goto et al., Correlations among brain gray matter volumes, age, gender, and hemisphere in healthy individuals, PloS One, vol.6, 2011.

A. Van-der-gucht, A. Verger, E. Guedj, G. Malandain, G. Hossu et al., Age-related changes in FDG brain uptake are more accurately assessed when applying an adaptive template to the SPM method of voxel-based quantitative analysis, Ann. Nucl. Med, vol.29, pp.921-928, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01245045

A. Varrone, J. C. Dickson, L. Tossici-bolt, T. Sera, S. Asenbaum et al., European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis, Eur. J. Nucl. Med. Mol. Imaging, vol.40, pp.213-227, 2013.

T. J. Whitford, C. J. Rennie, S. M. Grieve, C. R. Clark, E. Gordon et al., Brain maturation in adolescence: concurrent changes in neuroanatomy and neurophysiology, Hum. Brain Mapp, vol.28, pp.228-237, 2007.
DOI : 10.1002/hbm.20273

M. W. Willis, T. A. Ketter, T. A. Kimbrell, M. S. George, P. Herscovitch et al., Age, sex and laterality effects on cerebral glucose metabolism in healthy adults, Psychiatry Res, vol.114, pp.23-37, 2002.

H. Yoshizawa, Y. Gazes, Y. Stern, Y. Miyata, and S. Uchiyama, Characterizing the normative profile of 18F-FDG PET brain imaging: sex difference, aging effect, and cognitive reserve, Psychiatry Res, vol.221, pp.78-85, 2014.

, Ses principales limites sont qu'il ne s'agit pas de sujets "sains" à proprement parler, car, bien que dénué de pathologie neuro-oncologique ou neurodégénérative dopaminergique connue, ces sujets sont issus de l'acquisition d'images provenant de patient atteint de pathologie tumorale (neuro-endocrine) pour la plupart ; qu'il est issu d'acquisitions corps entier, et de ce fait, bien que très similaire en termes de coups à une acquisition cérébrale

E. R. Dorsey, R. Constantinescu, J. P. Thompson, K. M. Biglan, R. G. Holloway et al., Projected number of people with Parkinson disease in the most populous nations, Neurology, vol.68, issue.5, pp.384-390, 2005.

D. Salat, A. J. Noyce, A. Schrag, and E. Tolosa, Challenges of modifying disease progression in prediagnostic Parkinson's disease, Lancet Neurol, vol.15, issue.6, pp.637-685, 2016.

L. V. Kalia and A. E. Lang, Parkinson's disease, Lancet Lond Engl, vol.386, issue.9996, pp.896-912, 2015.

D. W. Dickson, Parkinson's Disease and Parkinsonism: Neuropathology. Cold Spring Harb Perspect Med, vol.2, 2012.

C. Hamani and A. M. Lozano, Physiology and pathophysiology of Parkinson's disease, Ann N Y Acad Sci, vol.991, pp.15-21, 2003.

J. Darcourt, A. Schiazza, N. Sapin, M. Dufour, M. J. Ouvrier et al., 18F-FDOPA PET for the diagnosis of parkinsonian syndromes, Q J Nucl Med Mol Imaging Off Publ Ital Assoc Nucl Med AIMN Int Assoc Radiopharmacol IAR Sect Soc Of, 2014.

S. Ikemoto, Brain reward circuitry beyond the mesolimbic dopamine system: A neurobiological theory, Neurosci Biobehav Rev, vol.35, issue.2, pp.129-50, 2010.

R. Malenka, E. Nestler, and H. S. Chapter, Molecular Neuropharmacology: A Foundation for Clinical Neuroscience, 2009.

K. A. Jellinger, Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway, Mol Chem Neuropathol, vol.14, issue.3, pp.153-97, 1991.

A. Samii, J. G. Nutt, and B. R. Ransom, Parkinson's disease, Lancet Lond Engl, vol.363, issue.9423, pp.1783-93, 2004.

W. Poewe, K. Seppi, C. M. Tanner, G. M. Halliday, P. Brundin et al., Parkinson disease. Nat Rev Dis Primer, vol.3, p.17013, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-00391622

C. D. Good, I. S. Johnsrude, J. Ashburner, R. N. Henson, K. J. Friston et al., A voxelbased morphometric study of ageing in 465 normal adult human brains, NeuroImage, vol.14, issue.1, pp.21-36, 2001.

M. Politis, G. Pagano, and F. Niccolini, Imaging in Parkinson's Disease, Int Rev Neurobiol, vol.132, pp.233-74, 2017.

M. K. Beyer, C. C. Janvin, J. P. Larsen, and D. Aarsland, A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry, J Neurol Neurosurg Psychiatry, vol.78, issue.3, pp.254-263, 2007.

E. J. Burton, I. G. Mckeith, D. J. Burn, E. D. Williams, O. Brien et al., Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls, Brain J Neurol, vol.127, pp.791-800, 2004.

T. R. Melzer, R. Watts, M. R. Macaskill, T. L. Pitcher, L. Livingston et al., Grey matter atrophy in cognitively impaired Parkinson's disease, J Neurol Neurosurg Psychiatry, vol.83, issue.2, pp.188-94, 2012.
DOI : 10.1136/jnnp-2011-300828

J. Pagonabarraga, I. Corcuera-solano, Y. Vives-gilabert, G. Llebaria, C. García-sánchez et al., Pattern of Regional Cortical Thinning Associated with Cognitive Deterioration in Parkinson's Disease, PLOS ONE, vol.8, issue.1, p.54980, 2013.

C. Tam, E. J. Burton, I. G. Mckeith, D. J. Burn, O. Brien et al., Temporal lobe atrophy on MRI in Parkinson disease with dementia A comparison with Alzheimer disease and dementia with Lewy bodies, Neurology, vol.64, issue.5, pp.861-866, 2005.

D. Weintraub, J. Doshi, D. Koka, C. Davatzikos, A. D. Siderowf et al., Neurodegeneration Across Stages of Cognitive Decline in Parkinson Disease, Arch Neurol, vol.68, issue.12, pp.1562-1570, 2011.

M. Zarei, N. Ibarretxe-bilbao, Y. Compta, M. Hough, C. Junque et al., Cortical thinning is associated with disease stages and dementia in Parkinson's disease, J Neurol Neurosurg Psychiatry, vol.84, issue.8, pp.875-81, 2013.

L. G. Apostolova, M. Beyer, A. E. Green, K. S. Hwang, J. H. Morra et al., Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia, Mov Disord, vol.25, issue.6, pp.687-95, 2010.
DOI : 10.1002/mds.22799

URL : http://europepmc.org/articles/pmc3068920?pdf=render

R. Camicioli, M. M. Moore, A. Kinney, E. Corbridge, K. Glassberg et al., Parkinson's disease is associated with hippocampal atrophy, Mov Disord, vol.18, issue.7, pp.784-90, 2003.
DOI : 10.1002/mds.10444

C. Junqué, B. Ramírez-ruiz, E. Tolosa, C. Summerfield, M. Martí et al., Amygdalar and hippocampal MRI volumetric reductions in Parkinson's disease with dementia, Mov Disord, vol.20, issue.5, pp.540-544, 2005.

A. J. Stoessl, S. Lehericy, and A. P. Strafella, Imaging insights into basal ganglia function, Parkinson's disease, and dystonia, Lancet Lond Engl, vol.384, issue.9942, pp.532-576, 2009.
DOI : 10.1016/s0140-6736(14)60041-6

URL : http://europepmc.org/articles/pmc4454525?pdf=render

M. Politis, Neuroimaging in Parkinson disease: from research setting to clinical practice, Nat Rev Neurol, vol.10, issue.12, pp.708-730, 2014.
DOI : 10.1038/nrneurol.2014.205

M. Janssen, Dopamine Transporter (DaT) SPECT Imaging, vol.6, 2012.

T. Ishikawa, V. Dhawan, K. Kazumata, T. Chaly, F. Mandel et al., Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET, J Nucl Med Off Publ Soc Nucl Med, vol.37, issue.11, pp.1760-1765, 1996.

S. A. Eshuis, R. P. Maguire, K. L. Leenders, S. Jonkman, and P. L. Jager, Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson's disease

, Eur J Nucl Med Mol Imaging, vol.33, issue.2, pp.200-209, 2006.

S. A. Eshuis, P. L. Jager, R. P. Maguire, S. Jonkman, R. A. Dierckx et al., Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson's disease and healthy controls, Eur J Nucl Med Mol Imaging, vol.36, issue.3, pp.454-62, 2009.

M. July, P. Santhanam, L. Giovanella, and G. Treglia, Role of positron emission tomography imaging in Multiple Endocrine Neoplasia syndromes, Clin Physiol Funct Imaging, 2016.

P. L. Jager, R. Chirakal, C. J. Marriott, A. H. Brouwers, K. P. Koopmans et al., 6-L18F-fluorodihydroxyphenylalanine PET in neuroendocrine tumors: basic aspects and emerging clinical applications, J Nucl Med Off Publ Soc Nucl Med, 2008.

E. Salmon, Pitfalls and Limitations of PET/CT in Brain Imaging, p.2017

R. Hilker, K. Schweitzer, S. Coburger, M. Ghaemi, S. Weisenbach et al., Nonlinear Progression of Parkinson Disease as Determined by Serial Positron Emission Tomographic Imaging of Striatal Fluorodopa F 18 Activity, Arch Neurol, vol.62, issue.3, pp.378-82, 2005.

R. Hilker, A. V. Thomas, J. C. Klein, S. Weisenbach, E. Kalbe et al., Dementia in Parkinson disease Functional imaging of cholinergic and dopaminergic pathways, Neurology, vol.65, issue.11, pp.1716-1738, 2005.

R. Nandhagopal, L. Kuramoto, M. Schulzer, E. Mak, J. Cragg et al., Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study, Brain, vol.132, issue.11, pp.2970-2979, 2009.

J. Talbot, K. Kerrou, F. Montravers, V. Nataf, and Y. Chevalme, FDOPA PET has clinical utility in brain tumour imaging: a proposal for a revision of the recent EANM guidelines, Eur J Nucl Med Mol Imaging, vol.34, issue.7, pp.1131-1132, 2007.

A. Becherer, G. Karanikas, M. Szabó, G. Zettinig, S. Asenbaum et al., Brain tumour imaging with PET: a comparison between [18F]fluorodopa and [11C]methionine, Eur J Nucl Med Mol Imaging, vol.30, issue.11, pp.1561-1568, 2003.
DOI : 10.1007/s00259-003-1259-1

W. D. Heiss, K. Wienhard, R. Wagner, H. Lanfermann, A. Thiel et al., F-Dopa as an amino acid tracer to detect brain tumors, J Nucl Med Off Publ Soc Nucl Med, vol.37, issue.7, pp.1180-1182, 1996.

J. M. Hoffman, W. P. Melega, T. C. Hawk, S. C. Grafton, A. Luxen et al., The Effects of Carbidopa Administration on 6-[18F]Fluoro-L-DOPA Kinetics in Positron Emission Tomography, J Nucl Med, vol.33, issue.8, pp.1472-1479, 1992.

W. D. Brown, T. R. Oakes, O. T. Dejesus, M. D. Taylor, A. D. Roberts et al., Fluorine-18-Fluoro-L-DOPA Dosimetry with Carbidopa Pretreatment, J Nucl Med, 1998.

, Nov, vol.1, issue.11, pp.1884-91

A. Van-der-gucht, A. Verger, E. Guedj, G. Malandain, G. Hossu et al., Agerelated changes in FDG brain uptake are more accurately assessed when applying an adaptive template to the SPM method of voxel-based quantitative analysis, Ann Nucl Med, vol.29, issue.10, pp.921-929, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01245045

M. Signorini, E. Paulesu, K. Friston, D. Perani, A. Colleluori et al., Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: A clinical validation of statistical parametric mapping, NeuroImage, vol.9, issue.1, pp.63-80, 1999.

K. Ishii, F. Willoch, S. Minoshima, A. Drzezga, E. P. Ficaro et al., Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains, J Nucl Med Off Publ Soc Nucl Med, 2001.

F. J. García-gómez, D. García-solís, F. J. Luis-simón, V. A. Marín-oyaga, F. Carrillo et al.,

, Rev Espanola Med Nucl E Imagen Mol, vol.32, pp.350-356, 2013.

J. D. Gispert, J. Pascau, S. Reig, R. Martínez-lázaro, V. Molina et al., Influence of the normalization template on the outcome of statistical parametric mapping of PET scans, NeuroImage, vol.19, issue.3, pp.601-613, 2003.

A. Kas, P. Payoux, M. Habert, Z. Malek, Y. Cointepas et al., Validation of a standardized normalization template for statistical parametric mapping analysis of 123IFP-CIT images, J Nucl Med Off Publ Soc Nucl Med, vol.48, issue.9, pp.1459-67, 2007.

A. Eusebio, J. Azulay, M. Ceccaldi, N. Girard, O. Mundler et al., Voxel-based analysis of whole-brain effects of age and gender on dopamine transporter SPECT imaging in healthy subjects, Eur J Nucl Med Mol Imaging, vol.39, issue.11, pp.1778-83, 2012.

M. Cordes, B. J. Snow, S. Cooper, M. Schulzer, B. D. Pate et al., Age-dependent decline of nigrostriatal dopaminergic function: a positron emission tomographic study of grandparents and their grandchildren, Ann Neurol, vol.36, issue.4, pp.667-70, 1994.

D. Eidelberg, S. Takikawa, V. Dhawan, T. Chaly, W. Robeson et al., Striatal 18Fdopa uptake: absence of an aging effect, J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab, vol.13, issue.5, pp.881-889, 1993.

G. V. Sawle, J. G. Colebatch, A. Shah, D. J. Brooks, C. D. Marsden et al., Striatal function in normal aging: implications for Parkinson's disease, Ann Neurol, 1990.

W. R. Martin, M. R. Palmer, C. S. Patlak, and D. B. Calne, Nigrostriatal function in humans studied with positron emission tomography, Ann Neurol, vol.26, issue.4, pp.535-577, 1989.

A. Laakso, H. Vilkman, J. Bergman, M. Haaparanta, O. Solin et al., Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects, Biol Psychiatry, vol.52, issue.7, pp.759-63, 2002.

J. C. Houk and S. P. Wise, Distributed modular architectures linking basal ganglia, cerebellum, and cerebral cortex: their role in planning and controlling action, Cereb Cortex N Y N, vol.5, issue.2, pp.95-110, 1991.
DOI : 10.1093/cercor/5.2.95

E. Bauer, M. Toepper, H. Gebhardt, B. Gallhofer, and G. Sammer, The significance of caudate volume for age-related associative memory decline, Brain Res, vol.1622, pp.137-185, 2015.

S. K. Madsen, A. J. Ho, X. Hua, P. S. Saharan, A. W. Toga et al., 3D maps localize caudate nucleus atrophy in 400 Alzheimer's disease, mild cognitive impairment, and healthy elderly subjects, Neurobiol Aging, vol.31, issue.8, pp.1312-1337, 2010.

H. Yoshizawa, Y. Gazes, Y. Stern, Y. Miyata, and S. Uchiyama, Characterizing the normative profile of 18F-FDG PET brain imaging: sex difference, aging effect, and cognitive reserve, Psychiatry Res, vol.221, issue.1, pp.78-85, 2014.

J. D. Ragland, A. R. Coleman, R. C. Gur, D. C. Glahn, and R. E. Gur, Sex differences in brainbehavior relationships between verbal episodic memory and resting regional cerebral blood flow, Neuropsychologia, vol.38, issue.4, pp.451-61, 2000.

M. W. Willis, T. A. Ketter, T. A. Kimbrell, M. S. George, P. Herscovitch et al., Age, sex and laterality effects on cerebral glucose metabolism in healthy adults, Psychiatry Res, vol.114, issue.1, pp.23-37, 2002.

V. Dhawan, Y. Ma, V. Pillai, P. Spetsieris, T. Chaly et al., Comparative analysis of striatal FDOPA uptake in Parkinson's disease: ratio method versus graphical approach, J Nucl Med Off Publ Soc Nucl Med, vol.43, issue.10, pp.1324-1354, 2002.

A. Jaimini, M. Tripathi, D. Souza, M. M. Panwar, P. Sharma et al., Utility of intrastriatal ratios of FDOPA to differentiate idiopathic Parkinson's disease from atypical parkinsonian disorders, Nucl Med Commun, vol.34, issue.5, pp.426-457, 2013.

P. Jokinen, H. Helenius, E. Rauhala, A. Brück, O. Eskola et al., Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls, J Nucl Med Off Publ Soc Nucl Med, vol.50, issue.6, pp.893-902, 2009.

M. Helali, P. Addeo, C. Heimburger, J. Detour, B. Goichot et al., Carbidopaassisted (18)F-fluorodihydroxyphenylalanine PET/CT for the localization and staging of non-functioning neuroendocrine pancreatic tumors, Ann Nucl Med, vol.30, issue.9, pp.659-68, 2016.

H. Timmers, M. Hadi, J. A. Carrasquillo, C. C. Chen, L. Martiniova et al., The Effects of Carbidopa on Uptake of 6-18F-Fluoro-l-DOPA in PET of Pheochromocytoma and Extraadrenal Abdominal Paraganglioma, J Nucl Med, vol.48, issue.10, pp.1599-606, 2007.

R. K. Salokangas, H. Vilkman, T. Ilonen, T. Taiminen, J. Bergman et al., High levels of dopamine activity in the basal ganglia of cigarette smokers, Am J Psychiatry, vol.157, issue.4, pp.632-636, 2000.

V. De and L. A. Recherche, Cet article est soumis à publication (NeuroImage Clinical) et est accepté en présentation orale au congrès de l'European Association of Nuclear Medicine à Viennes en octobre, 2017.